In First of Its Kind Legislation, Louisiana Cracks Down on White-Bagging Requirements

Louisiana has just enacted a law stopping insurers or their pharmacy benefit managers from requiring or pressuring in-network providers to accept "white bagging" of physician-administered drugs. | Shutterstock
Louisiana Gov. John Bel Edwards (D) has signed legislation stopping insurers or their pharmacy benefit managers from requiring or pressuring in-network providers to obtain physician-administered drugs exclusively from pharmacies in the insurer’s network.

Please Login or

Read More »

More Than a Third of State Lawmakers Accept Pharma Campaign Contributions, Analysis Shows

More than one-third of all state lawmakers nationwide accepted at least one pharmaceutical industry campaign contribution during the past two years, an analysis of campaign finance records by news organization STAT found.
In the last two years, over one-third of all state lawmakers nationwide accepted at least one pharmaceutical industry campaign contribution, news organization STAT reports.

Please Login or Become a Paid Subscriber to View this Content

Read More »

Vermont Places 340B-Related Strictures on PBMs and Adds Protections to Contract Pharmacies

Vermont’s legislature has voted to bar pharmacy benefit managers (PBMs) from requiring claims modifiers on 340B-purchased drugs, except for claims paid directly or indirectly by Medicaid. | Tony Fischer https://www.flickr.com/photos/tonythemisfit/
Vermont’s legislature has voted to bar pharmacy benefit managers (PBMs) from requiring claims modifiers on 340B-purchased drugs, except for claims paid directly or indirectly by Medicaid.

Please Login or Become a Paid Subscriber to View this

Read More »

Montana Enacts Expansive Bill Intended to Protect 340B Providers

Montana Gov. Greg Gianforte (R) signed a bill last week forbidding PBMs from reimibursing 340B covered entities and their contract pharmacies less for drugs than other pharmacies.
Montana has passed a law barring pharmacy benefit managers (PBMs) from excluding 340B contract pharmacies from participating in their networks.

Please Login or Become a Paid Subscriber to View this Content

Read More »

North Dakota Is the Latest State to Pass a 340B Non-Discrimination Law

The North Dakota legislature (above) passed, and Gov. Doug Burgum (R) has signed, legislation prohibiting pharmacy benefit managers from discriminating against 340B covered entities or their contract pharmacies.
North Dakota Gov. Doug Burgum (R) has signed legislation prohibiting pharmacy benefit managers (PBMs) from discriminating against 340B covered entities or their contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

Read More »

340B Non-Discrimination Bills Signed in Arkansas and Indiana and Passed in Tennessee

Tennessee lawmakers this week passed a 340B non-discrimination bill, sending it to Gov. Bill Lee for his signature.
Arkansas’s and Indiana’s governors have signed bills in recent days to prevent pharmacy benefit managers (PBMs) from discriminating against 340B covered entities, and a similar bill is awaiting the Tennessee governor’s signature.

Please Login or Become

Read More »

State Attorney General Is Investigating Lilly and AstraZeneca’s 340B Pricing

Eli Lilly and AstraZeneca are the latest drug makers to disclose that they have been subpoenaed by Vermont's top law enforcement official for documents and information about their participation in 340B. | Shutterstock
Eli Lilly and AstraZeneca are the latest drug makers to disclose they have received a subpoena from the Vermont attorney general’s office related to their denials of 340B ceiling prices on drugs shipped to contract pharmacies.
Read More »

Arkansas Passes First-of-its-Kind Bill to Counter Pharma’s 340B Contract Pharmacy Moves

Arkansas state lawmakers this week passed what is thought to be the first bill in the nation to address drug manufacturers' denials of 340B pricing on drugs dispensed by contract pharmacies. | Jim Bowen/Flickr
The Arkansas legislature on Tuesday passed what is believed to be the first bill nationally to address pharmaceutical manufacturer denials of 340B pricing on drugs when they are dispensed by contract pharmacies.

Please Login or Become

Read More »

Vermont AG Issues Subpoena to Novartis for 340B Documents and Information

Novartis is the second known drug manufacturer subpoenaed by the Vermont attorney general over manufacturer denials of or restrictions on 340B pricing for drugs shipped to contract pharmacies.

Vermont’s top law enforcement official has asked a second drug manufacturer—Novartis—for documents and information concerning the company’s participation in the 340B program in the state.

Tuesday in its interim financial report for the first quarter of 2021, the Swiss

Read More »

NY State 340B Providers Get More Time to Challenge Reimbursement Change

New York lawmakers and Gov. Andrew Cuomo agreed on budget legislation this week that will delay a Medicaid drug benefit transfer opposed by 340B entities for two years.
New York state lawmakers and Gov. Andrew Cuomo (D) agreed this week to postpone transferring Medicaid managed care prescription drug benefits to Medicaid fee for service (FFS) for two years, temporarily averting a significant financial loss to 340B covered entities.
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
×

Sign up for news summaries and alerts from 340B Report